Mayuko Tokuda

发表

Combination therapy with anti-programmed cell death 1 antibody plus angiokinase inhibitor exerts synergistic antitumor effect against malignant mesothelioma via tumor microenvironment modulation.

K. Kitajima, M. Ohmuraya, T. Kijima, 2023, Lung cancer.